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The immune reconstitution inflammatory syndrome 
(IRIS) is a frequent early complication of antiretroviral 
therapy (ART), particularly in patients who commence 
ART with low CD4 counts and established opportunistic 
infections. IRIS in HIV-infected patients results from 
a pathological inflammatory response to pre-existing 
infective, host or other antigens, alive or dead, causing 
clinical deterioration after initiating ART.1 The most 
common forms of IRIS occur in association with 
mycobacterial and herpesvirus infections.2 
Adolescents and young adults comprise an increasing 
proportion of new HIV infections both in developing 
and developed countries, and little is known regarding 
HIV IRIS in this group. As the ART roll-out has gathered 
pace since 2004 in resource-limited settings, adolescent 
IRIS has emerged as a clinical challenge. We describe 
adolescent/young adult patients who presented to our 
clinic with IRIS events.
METHODS
The study was performed at the Adult Infectious 
Diseases Institute (IDI) at Mulago Hospital, Kampala, 
Uganda. The AIDC is part of the Makerere University 
Infectious Diseases Institute and provides HIV care, 
including free ART, to HIV-infected patients with 
a CD4+ count <200 cells/µl or with World Health 
Organization stage IV disease. The study was approved 
by the ethics panel and the Institutional Review Board 
since this was a case series. Among our adolescent/
young adult cohort aged 16 - 24 years of about 480, 
we have seen 6 cases of IRIS, including cryptococcal 
meningitis IRIS, Kaposi’s sarcoma IRIS, herpes zoster 
IRIS, pulmonary tuberculosis IRIS and 2 cases of 
oral candidiasis IRIS within the past 12 months. The 
incidence of IRIS after initiation of HAART was 1.25%. 
The median age of presentation was 22 years and the 
median CD4+ count before commencing ART 65 cells/
µl. IRIS presented a median of 6 weeks from the start 
of HAART (range 3 - 16 weeks). 
Mycobacteria are by far the most common pathogens 
associated with IRIS in HIV-infected patients.3-7 Other 
infections that have been associated with IRIS events 
include varicella zoster, herpes simplex, meningeal 
cryptococcosis, hepatitis, cytomegalovirus retinitis, 
progressive multifocal leuco-encephalopathy and 
intestinal parasites. While the majority of IRIS events 
are infectious in nature, auto-immune IRIS reactions 
have also been described in adults.8
DISCUSSION
IRIS is a condition seen in some cases of AIDS or 
immunosuppression, in which the immune system 
begins to recover but then responds to a previously 
acquired opportunistic infection with an overwhelming 
inflammatory response that paradoxically makes the 
symptoms of infection worse.9 It is thought that the 
immunopathological response initiated by HAART 
restores the immune response against pathogenic 
antigens.10 There is paradoxical worsening of pre-
existing infectious processes following initiation of 
HAART in HIV-infected individuals.9
 
These cases highlight the risks faced during 
immune reconstitution in adolescent and young 
adult patients who commence ART with advanced 
immunosuppression. 
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CONCLUSION
IRIS occurs in adolescents and young adults, but little 
is known about IRIS in general and minimal research 
has been conducted in the adolescent/young adult age 
group. 
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Age (yrs)                         CD4 counts at initiation of               
HAART (cells/µl)
IRIS condition Time from start of HAART 
to onset of IRIS (wks)
19 45 Pulmonary tuberculosis   4
20 77 Oral candidiasis   6
21 56 Kaposi’s sarcoma   3
23 65 Herpes zoster   9
24 65 Cryptococcal meningitis 16
24 73 Oral candidiasis   6
table i. table diSplaying ageS, abSolute cd4 countS and preSentation time oF iriS among 
adoleScentS/young adultS over 1 year at the inFectiouS diSeaSeS inStitute, Kampala
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To the Editor: We at the South African National 
Blood Service (SANBS) are acutely aware of the issues 
surrounding the exclusion of men who have sex with 
men (MSM) from donating blood and the negative 
emotions that surround this policy. I would like to assure 
readers that SANBS does not make such decisions 
lightly, and we constantly review policies based on the 
latest scientific findings. It is perhaps time to review 
the basis of the current policy and engage in debate on 
its scientific merit.
It is, however, important to clarify a few misconceptions 
regarding our policies on the sexual activities of our 
donors.
In an editorial comment on 6 January 2010, the editor 
of The Herald newspaper in Port Elizabeth stated: ‘A 
pattern of multiple partners or of unprotected sex … is 
clearly also high-risk and yet heterosexual donors who 
may be sexually reckless are spared prying questions 
and the possible refusal of their offer of blood.’1 This 
statement is factually incorrect. When donating blood, 
all donors, whatever their sexual orientation, have to 
answer very personal questions regarding their sexual 
activities during the preceding 6 months.2
Any person who has had any form of potentially 
high-risk sexual activity will be deferred for a period of 
6 months following the high-risk activity. A donor who 
has multiple sex partners will be regarded as being at 
potentially high risk regardless of sexual orientation. 
At no point does SANBS suggest that high-risk sexual 
practices are exclusive to the gay community, hence 
the self-exclusion questionnaire’s comprehensive set 
of questions regarding various sexual activities and 
practices.
There are over 450 rules guiding donor selection with 
SANBS’s policy on blood donations 
from men who have sex with men
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regard to medical conditions and lifestyle, and there 
are many groups of people whom we defer from 
donating, either temporarily or permanently.3 Some 
individuals in these groups may have a very low risk of 
blood-borne infections and their blood would probably 
be safe to give to patients, but since it is impossible to 
identify specific individuals at low risk it is safest to 
ask everyone in the higher risk groups not to donate 
blood. 
The request not to donate blood can be disappointing 
and frustrating to some people who wish to do so. Our 
decisions are based on information and research about 
the effects our policies on blood supply safety, not 
out of a desire to discriminate against any particular 
group. 
The aims of donor selection are to: 
n    select donors whose blood is most unlikely to 
transmit any infection 
n    collect enough blood to meet patients’ needs 
n    make sure that donors themselves come to no harm 
through the blood donation process. 
We have to balance these three aims while keeping the 
selection process clear and simple, bearing in mind that 
almost a million units of blood are collected each year 
– a mammoth task complicated by stringent quality 
control and logistics.
The preliminary findings of recent studies among MSM, 
such as the JEMS study conducted in Johannesburg and 
Durban and the Soweto Men’s Study, have found their 
HIV prevalence  to be more than double the Actuarial 
Scientists of South Africa (ASSA)’s estimate of  a 15.5% 
national HIV prevalence and  the UNAIDS estimate of 
18.1%.4-8
South Africa was one of the first countries in the world 
to lift the total ban on men who have sex with men 
donating blood. Other countries such as Sweden are 
only now starting to follow our example. We still have 
among the most progressive policies regarding MSM in 
the world, and while this may not be much consolation 
to gay men in stable relationships, it is testimony to 
SANBS’s commitment to be as inclusive as possible 
with regard to the community we serve.
Internationally this is a very topical discussion. It is 
interesting to note that in the USA some politicians 
have called for the lifting of the ban against MSM 
donating blood and that this was countered by the 
Haemophiliac Society, a group whose members were 
severely affected by infected blood during the 1980s.
It is easy to get lost in all the numbers and emotions, 
but at SANBS we have the very tough responsibility of 
weighing up the right of an individual to donate blood 
against that of a patient to receive blood that is as 
safe as it is humanly possible to make it. The decision 
on which groups of the population will be or should 
be allowed to donate must be taken on the basis of 
scientific merit and the blood service’s ability to 
implement policies that are clear and concise.
Karin van den Berg
Zone Medical Officer, Eastern Cape
South African National Blood Service
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ERRATUM
In ‘Changes to the ART guidelines – an overview’, which appeared on pp. 28 - 30 of the April 2010 issue of 
the Journal, the first sentence under the heading ‘National regimens’ and the heading to Table I should have 
read ‘National regimens for adults and adolescents’ and not ‘National regimens for children and adolescents’. 
We apologise for these errors and have corrected them on the web version of the article, in which there are 
also other adjustments.
